Showing results (121-130 of 217) with videos related to
Sort By:
Pageof 22
Anticancer Research|December 7, 2016
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral ChemotherapyMaria Ornella Nicoletto, Alessandra Casarin, Alessandra Baldoni, et al.Apoptosis : an International Journal on Programmed Cell Death|July 6, 2013
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performanceMaria Serena Piccinno, Elena Veronesi, Pietro Loschi, et al.NPJ Breast Cancer|August 3, 2021
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapyMaria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, et al.NPJ Breast Cancer|May 20, 2022
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatmentFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneJoseph A Sparano, Eduard Vrdoljak, Oliver Rixe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE StudyEdith A Perez, Carlos Barrios, Wolfgang Eiermann, et al.Breast Cancer Research and Treatment|March 15, 2017
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trialsM V Dieci, A Frassoldati, D Generali, et al.Journal of Women'S Health (2002)|July 3, 2018
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer CenterMaria Vittoria Dieci, Cristina Ghiotto, Caterina Barbieri, et al.Frontiers in Oncology|March 29, 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA AnalysisLoredana Urso, Grazia Vernaci, Jessica Carlet, et al.British Journal of Cancer|May 8, 2020
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancerElisabetta Zulato, Ilaria Attili, Alberto Pavan, et al.Pageof 22